Literature DB >> 36208333

Is endolymphatic sac surgery an efficient treatment of Menière's disease patients? A systematic literature search and meta-analysis.

Franziska A Szott1, M Westhofen2, S Hackenberg2.   

Abstract

PURPOSE: The purpose of this work is to assess the treatment efficiency of endolymphatic sac surgery in patients with Menière's disease.
METHODS: This study provides a systematic literature review and meta-analysis based on the guidelines of the Cochrane Collaboration and the Preferred Reporting Items for Systematic reviews and Meta-Analyses protocol. The main inclusion criteria of the literature review were the classification categories according to the American Academy of Otolaryngology-Head and Neck Surgery guidelines of 1985 and 1995.
RESULTS: An effect of 9.25 dB postoperative weighted average hearing loss in surgically treated individuals is classified as "clinically not significant" according to American Academy of Otolaryngology-Head and Neck Surgery 85/95. In contrast, the deterioration by 26.23% in speech comprehension is considered as "clinically significant." An improvement of functional level scale assessment by two categories and vertigo control by assessment in category B can be observed.
CONCLUSION: The findings of this meta-analysis indicate that endolymphatic sac surgery may be beneficial as a treatment for Menière's disease in terms of a positive impact on functional level scale and vertigo control while yielding a negative impact on pure tone average hearing loss and on speech comprehension.
© 2022. The Author(s).

Entities:  

Keywords:  Endolymphatic surgery; Menière's disease; Meta-analysis; Systematic review; Vertigo

Year:  2022        PMID: 36208333     DOI: 10.1007/s00405-022-07580-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


  21 in total

1.  The Saccus Endolymphaticus and an Operation for Draining for the Relief of Vertigo.

Authors:  G Portmann
Journal:  Proc R Soc Med       Date:  1927-10

2.  Menière's disease: results of treatment with the endolymphatic subarachnoid shunt compared with the endolymphatic mastoid shunt.

Authors:  D E Brackmann; R L Nissen
Journal:  Am J Otol       Date:  1987-07

3.  Sac-vein decompression for intractable Meniere's disease: two-year treatment results.

Authors:  G J Gianoli; M J Larouere; J M Kartush; J Wayman
Journal:  Otolaryngol Head Neck Surg       Date:  1998-01       Impact factor: 3.497

4.  Endolymphatic mastoid shunt versus endolymphatic sac decompression for Ménière's disease.

Authors:  George M Brinson; Douglas A Chen; Moisés A Arriaga
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

5.  Endolymphatic sac surgery versus tenotomy of the stapedius and tensor tympani muscles in the management of patients with unilateral definite Meniere's disease.

Authors:  Silviu Albu; Gregorio Babighian; Maurizio Amadori; Franco Trabalzini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-07       Impact factor: 2.503

Review 6.  [Menière's disease : evidence and controversies].

Authors:  M Westhofen
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

7.  Placebo effect in surgery for Meniere's disease: a three-year follow-up study of patients in a double blind placebo controlled study on endolymphatic sac shunt surgery.

Authors:  P Bretlau; J Thomsen; M Tos; N J Johnsen
Journal:  Am J Otol       Date:  1984-10

Review 8.  Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study.

Authors:  Wichor M Bramer; Melissa L Rethlefsen; Jos Kleijnen; Oscar H Franco
Journal:  Syst Rev       Date:  2017-12-06

Review 9.  Recent surgical options for vestibular vertigo.

Authors:  Stefan Volkenstein; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.